Related content

Towards More Effective Liver Allocation Criteria for Hepatocellular Carcinoma: Tumor Response to Locoregional Therapy

By Lin Yiing  

Annals of Surgical Oncology, Vol. 18, Iss. 9, 2011-09 ,pp. : 2416-2418

Springer Publishing Company

Access to resources Recommend Favorite

mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)

By Prajapati H. J.   Spivey J. R.   Hanish S. I.   El-Rayes B. F.   Kauh J. S.   Chen Z.   Kim H. S.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 965-973

Oxford University Press

Access to resources Recommend Favorite

Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in nonviral hepatocellular carcinoma treated with transarterial chemoembolization

By          

Oncology Letters, Vol. 7, Iss. 5, 2014-01 ,pp. : 1704-1710

Spandidos Publications

Access to resources Recommend Favorite

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study

By Luo Jun  

Annals of Surgical Oncology, Vol. 18, Iss. 2, 2011-02 ,pp. : 413-420

Springer Publishing Company

Access to resources Recommend Favorite

Sorafenib in combination with transarterial chemoembolization in Chinese patients with hepatocellular carcinoma: a subgroup interim analysis of the START trial

By Han Guohong   Yang Jijin   Shao Guoliang   Teng Gaojun   Wang Maoqiang   Yang Jianyong   Liu Zhaoyu   Feng Gansheng   Yang Renjie   Lu Ligong   Chao Yee   Wang Jianhua  

Future Oncology, Vol. 9, Iss. 3, 2013-03 ,pp. : 403-410

Future Medicine

Access to resources Recommend Favorite